Orasis Pharmaceuticals
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals has raised €25M across 1 funding round from 2 investors, most recently a round in Sep 2020. Based in Herzliya, Israel; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€25M
€25,482,035
Funding rounds
1
Investors
2
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearOrasis Pharmaceuticals — funding by year — interactive chart.
Data table
| Orasis Pharmaceuticals — funding by year | |
|---|---|
| 2020 | €25M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-10 | Other | €25M | Bluestem Capital,Visionary Venture Fund | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData